Related Experiment Videos
[Primary dysmenorrhoea and hyperprolactinemia (author's transl)].
Geburtshilfe Und Frauenheilkunde
|July 1, 1978
Summary
Severe primary dysmenorrhea affects many young women. This study found hyperprolactinemia in most patients, with bromocriptine treatment significantly improving symptoms.
Area of Science:
- Gynecology
- Endocrinology
- Reproductive Health
Context:
- Severe primary dysmenorrhea impacts 5-10% of young women, disrupting monthly activities.
- Hyperprolactinemia, elevated prolactin levels, is investigated as a potential factor.
- Premenstrual tension is also considered in relation to dysmenorrhea.
Purpose:
- To investigate the correlation between hyperprolactinemia and severe primary dysmenorrhea.
- To assess the efficacy of bromocriptine (parlodel) in treating women with dysmenorrhea and hyperprolactinemia.
Summary:
- Hyperprolactinemia was identified in 13 out of 15 women with severe primary dysmenorrhea.
- All patients were confirmed to not have pituitary tumors and received bromocriptine treatment.
- Eight patients experienced complete symptom relief, and five showed significant improvement.
Impact:
- Suggests a link between elevated prolactin levels and severe menstrual pain.
- Bromocriptine shows promise as an effective treatment for this condition.
- Highlights the importance of considering hormonal imbalances in managing dysmenorrhea.